Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The varieties of psychosis in multiple sclerosis: A systematic review of cases.
Camara-Lemarroy CR, Ibarra-Yruegas BE, Rodriguez-Gutierrez R, Berrios-Morales I, Ionete C, Riskind P. Camara-Lemarroy CR, et al. Among authors: riskind p. Mult Scler Relat Disord. 2017 Feb;12:9-14. doi: 10.1016/j.msard.2016.12.012. Epub 2016 Dec 23. Mult Scler Relat Disord. 2017. PMID: 28283114 Review.
Relationships between multiple sclerosis and depression.
Byatt N, Rothschild AJ, Riskind P, Ionete C, Hunt AT. Byatt N, et al. Among authors: riskind p. J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):198-200. doi: 10.1176/jnp.23.2.jnp198. J Neuropsychiatry Clin Neurosci. 2011. PMID: 21677250
Branching enzyme deficiency: expanding the clinical spectrum.
Paradas C, Akman HO, Ionete C, Lau H, Riskind PN, Jones DE, Smith TW, Hirano M, Dimauro S. Paradas C, et al. Among authors: riskind pn. JAMA Neurol. 2014 Jan;71(1):41-7. doi: 10.1001/jamaneurol.2013.4888. JAMA Neurol. 2014. PMID: 24248152 Free PMC article.
gMS-Classifier1 does not predict disability progression in multiple sclerosis.
van Rossum JA, Killestein J, Villar LM, Riskind PN, Freedman MS, Teunissen C. van Rossum JA, et al. Among authors: riskind pn. Mult Scler. 2019 Jun;25(7):1010-1011. doi: 10.1177/1352458518798048. Epub 2018 Aug 31. Mult Scler. 2019. PMID: 30168749 Free PMC article. No abstract available.
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
Govindarajan KA, Datta S, Hasan KM, Choi S, Rahbar MH, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA; MRI Analysis Center at Houston; CombiRx Investigators Group. Govindarajan KA, et al. Hum Brain Mapp. 2015 Oct;36(10):3749-3760. doi: 10.1002/hbm.22875. Epub 2015 Jun 19. Hum Brain Mapp. 2015. PMID: 26096844 Free PMC article. Clinical Trial.
Vitamin D and multiple sclerosis.
Weinstock-Guttman B, Mehta BK, Ramanathan M, Karmon Y, Henson LJ, Halper J, Riskind P. Weinstock-Guttman B, et al. Among authors: riskind p. Neurologist. 2012 Jul;18(4):179-83. doi: 10.1097/NRL.0b013e31825bbf35. Neurologist. 2012. PMID: 22735240 Review.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.
42 results